Item 1A. Risk Factors
Item
1A. Risk Factors
Generally,
as a smaller reporting company, we are permitted to omit risk factors. However, we believe the following Risk Factors are material
to our business. These do not encompass all risks related to our operations.
You
should carefully consider the risks described below together with all of the other information included in this annual report
before making an investment decision with regard to our securities. The statements contained in or incorporated herein that are
not historic facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results
to differ materially from those set forth in or implied by forward-looking statements. If any of the following risks actually
occurs, our business, financial condition or results of operations could be harmed. In that case, you may lose all or part of
your investment. In addition to the other information provided in this prospectus, you should carefully consider the following
risk factors in evaluating our business before purchasing any of our common stock.
Risks
Related to Our Financial Condition
Since
our inception, we have been insolvent and have required debt and equity financing to maintain operations.
Since
our inception, we have failed to create cashflows from revenues sufficient to cover basic costs. As a result, we have relied heavily
on debt and equity financing. Equity financing, in particular, has created a dilutive effect on our common stock, which has hampered
our ability to attract reasonable financing terms. For the foreseeable future, we will continue to rely upon debt and equity financing
to maintain operation of the Company and its subsidiaries.
We
have generated minimal revenues from operations, which makes it difficult for us to evaluate our future business prospects and
make decisions based on those estimates of our future performance.
As
of December 31, 2018, we had generated insufficient revenues. As a consequence, it is difficult, if not impossible, to forecast
our future results based upon our historical data. Our projections are based upon our best estimates on future growth. Because
of the related uncertainties, we may be hindered in our ability to anticipate and timely adapt to increases or decreases in sales,
revenues, or expenses. If we make poor budgetary decisions as a result of unreliable data, we may never become profitable or incur
losses, which may result in a decline in our stock price.
There
is substantial doubt about our ability to continue as a going concern and if we are unable to generate significant revenue or
secure additional financing, we may be unable to implement our business plan and grow our business.
We
are an emerging growth company and are in the process of selling and developing our products. Consequently, we have not generated
enough revenues as of the date of this prospectus. We have an accumulated deficit and have incurred operating losses since our
inception and expect losses to continue during the remainder of fiscal 2019. Our independent registered public accounting firm
has indicated in their report that these conditions raise substantial doubt about our ability to continue as a going concern for
a period of 12 months from the issuance date of this report. The continuation of our business as a going concern is dependent
upon the continued financial support from our stockholders.
8
There
is uncertainty regarding our ability to grow our business to a greater extent than we can with our existing financial resources,
also described above, without additional financing. We have no agreements, commitments, or understandings to secure additional
financing at this time. Our long-term future growth and success is dependent upon our ability to continue selling our products
and services, generate cash from operating activities and obtain additional financing. There is no assurance that we will be able
to continue selling our products and services, generate sufficient cash from operations, sell additional shares of common stock
or borrow additional funds. Our inability to obtain additional cash could have a material adverse effect on our ability to grow
our business to a greater extent than we can with our existing financial resources, also described above.
Expenses
required to operate as a public company will reduce funds available to implement our business plan and could negatively affect
our stock price and adversely affect our results of operations, cash flow and financial condition.
Operating
as a public company is more expensive than operating as a private company, including additional funds required to obtain outside
assistance from legal, accounting, investor relations, or other professionals that could be costlier than planned. We may also
be required to hire additional staff to comply with additional SEC reporting requirements. We anticipate that the cost of SEC
reporting will be approximately $100,000 annually. Our failure to comply with reporting requirements and other provisions of securities
laws could negatively affect our stock price and adversely affect our results of operations, cash flow and financial condition.
If we fail to meet these requirements, we will be unable to secure a qualification for quotation of our securities on the OTCQB,
or if we have secured a qualification, we may lose the qualification and our securities would no longer trade on the OTCQB. Further,
if we fail to meet these obligations and consequently fail to satisfy our SEC reporting obligations, investors will then own stock
in a company that does not provide the disclosure available in quarterly, annual reports and other required SEC reports that would
be otherwise publicly available leading to increased difficulty in selling their stock due to our becoming a non-reporting issuer.
Our
common stock trades below $0.01 and is substantially at risk of being delisted from the OTCQB Tier.
OTC
Markets requires, amongst other things, that in order to qualify for OTCQB listings, an issuer have their common stock trade above
$0.01 per share. If the bid price closes below $0.01 for 30 consecutive days, an issuer will be notified of their bid price deficiency
and has a 90-day cure period, where by the stock’s closing bid price must be greater than $0.01 for 10 consecutive days.
On February 5, 2019, we received notice of our bid price deficiency from OTC Markets, giving us until May 6, 2019 to cure the
bid price deficiency. If we fail to cure, we will be dropped to the OTCPink tier. This could adversely affect the Company and
our ability to raise funds through equity financing as OTCPink listings are generally deemed to have a greater risk. In addition,
our shareholders face the risk that in order to cure the bid price deficiency, the Board of Directors may recommend a reverse
stock split to the shareholders. As Nicholas Campanella has a majority of the voting rights, such recommendation would likely
be affirmed which could result in the risk of greater dilution to the value of our shareholders.
Risks
Related to Our Business
We
rely on our Chief Executive Officer to operate our business. The loss of our Chief Executive Officer could have a material adverse
effect on our business.
Our
operations are highly dependent upon the efforts of our Chief Executive Officer, Nicholas Campanella. The success of our Company
is heavily reliant upon the efforts and resources of Nicholas Campanella. The loss of our Chief Executive Officer would have a
material adverse effect on our business, financial condition, and results of operations, particularly if we are unable to hire
or relocate and integrate suitable replacements on a timely basis or at all. Further, in order to continue to grow our business,
we will need to expand our senior management team. We may be unable to attract or retain these persons. This could hinder our
ability to grow our business and could disrupt our operations or otherwise have a material adverse effect on our business.
9
We
are unable to attract additional management personnel and members to our Board of Directors.
Due
to our insolvency, we are unable to dedicate any amount of cashflows to executive salaries and/or directors’ and officers’
insurance, therefore we are unable to attract additional executive personnel or Board Members. Until we can secure, at a minimum
directors’ and officers’ insurance, the executive duties shall remain with our Chief Executive Officer.
The
current ownership has the effect of concentrating voting control with our Chief Executive Officer and his family; this limits
our other stockholders’ and your ability to influence corporate matters.
Nicholas
Campanella currently holds 12,000,000 shares of Series A Preferred Stock. Each share of Series A Preferred Stock is entitled to
125 votes per share. As a result, Nicholas Campanella has 1,500,000,000 voting rights. As a result of this concentration of voting
power, Nicholas Campanella will have significant influence over the management and affairs of the Company and control over matters
requiring stockholder approval, including the election of directors and significant corporate transactions, such as mergers or
other sales of the Company or our assets, for the foreseeable future. This concentration of voting control will limit your ability
to influence corporate matters and could adversely affect the market price of our Common Stock once a market is established.
Our
director and officer, Nicholas Campanella will control and make corporate decisions that may differ from those that might be made
by the other shareholders.
Due
to the controlling amount of their share ownership in our Company, Nicholas Campanella will have a significant influence in determining
the outcome of all corporate transactions, including the power to prevent or cause a change in control. His interests may differ
from the interests of other stockholders and thus result in corporate decisions that are disadvantageous to other shareholders.
Our
director and officer, Nicholas Campanella, holds substantial debt that is convertible into common stock, resulting in even greater
control over the Company.
Nicholas
Campanella holds convertible promissory notes in excess of $600,000, making Nicholas Campanella the largest creditor of the Company.
The convertible promissory notes are convertible into common stock at rate of a 50% discount to market. Our current market cap
is lower than $400,000. If Nicholas Campanella were to either convert his promissory notes or foreclose upon the limited assets
of the Company, we would likely have to file for bankruptcy.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.